Skip to main content

Proteomic Analysis of Laser Microdissected Ovarian Cancer Tissue with SELDI-TOF MS

  • Protocol
  • First Online:
Laser Capture Microdissection

Part of the book series: Methods in Molecular Biology ((MIMB,volume 755))

Abstract

The evolution of ovarian cancer will highly depend on platinum sensitivity or resistance. In an attempt to better understand this mechanism of resistance, we combined laser microdissection (LMD) of ovarian tumor cells with mass spectrometric techniques. To obtain disease-specific markers we isolated ovarian tumor cells with LMD without contamination of surrounding cells. Proteins were extracted by chemical lysis and subsequent peptide and protein information was gathered using surface-enhanced laser desorption/ionization-time of flight mass spectrometry.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Heintz APM, Odicino F, Maisonneuve P, Quinn MA, Benedet JL and Creasman WT et al. (2006) Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynaecological Cancer. Int J Gynaecol Obstet 95 (suppl. 1), S161–192.

    Google Scholar 

  2. Martin LP, Hamilton TC, Schilder RJ. (2008) Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 14,1291–1295.

    Article  CAS  Google Scholar 

  3. Cadron I, Van Gorp T, Timmerman D, Amant F, Waelkens E, Vergote I. (2009) Application of proteomics in ovarian cancer: which sample should be used? Gynecol Oncol 115,497–503.

    Article  CAS  Google Scholar 

  4. Yan XD, Pan LY, Yuan Y, Lang JH, Mao N. (2007) Identification of platinum resistant associated proteins through proteomic analysis of human ovarian cancer cells and their platinum resistant sub lines. J Proteome Res 6,772–780.

    Article  CAS  Google Scholar 

  5. Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, et al. (2006) Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5,433–443.

    CAS  Google Scholar 

  6. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, et al. (2006) Serine proteaseHtrA1 modulates chemotherapy induced cytotoxicity. J Clin Invest 116,1994–2004.

    Article  CAS  Google Scholar 

  7. Le Moguen K, Lincet H, Deslandes E, Hubert-Roux M, Lange C, Poulain L, et al. (2006) Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10. Proteomics 6,5183–5192.

    Article  Google Scholar 

  8. Song J, Shih IeM, Salani R, Chan DW, Zhang Z. (2007) Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin Cancer Res 13, 6842–6849.

    Article  CAS  Google Scholar 

  9. Cadron I, Van Gorp T, Amant F, Vergote I, Moerman Ph, Waelkens E, Daemen A, Van de Plas R, De Moor B, Zeillinger R. (2009) The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res. 29, 1039–1045.

    Google Scholar 

  10. Schutze K, Clement-Sengewald A, Catch and move-cut or fuse. Nature 1994; 368:667–669.

    Article  CAS  Google Scholar 

  11. Schultze K, Lahr G, Burgemeister R. (2000) The force of focused light in different areas of cell and molecular biology. J Mol Med 78, B21.

    Google Scholar 

  12. Melle C, Ernst G,Schimmel B, Bleul A, Thieme H, Kaufmann R, Mothes H, Settmacher U, Claussen U, Halbhuber KJ, Von Eggeling F. (2005) Discovery and identification of alfa defnsins as low abundant tumor derived serum markers in colorectal cancer. Gastroenterology 129, 66–73.

    Article  CAS  Google Scholar 

  13. Diaz JL, Cazares LH, Corica A, Semmes OJ. (2004) Selective capture of prostatic basal cells and secretory epitheial cells for proteomic and genomic analysis. Urologic Oncology 329–336.

    Google Scholar 

  14. Kwapiszewska G, Meyer M, Bogumil R, Bohle RM, Seeger W, Weissmann N, Fink L. (2004) Identification of proteins in laser microdissected small cell numbers by SELDI-TOF and Tandem MS, BMC Biotechnology 4, 30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabelle Cadron .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Cadron, I., Van Gorp, T., Moerman, P., Waelkens, E., Vergote, I. (2011). Proteomic Analysis of Laser Microdissected Ovarian Cancer Tissue with SELDI-TOF MS. In: Murray, G. (eds) Laser Capture Microdissection. Methods in Molecular Biology, vol 755. Humana Press. https://doi.org/10.1007/978-1-61779-163-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-163-5_12

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-162-8

  • Online ISBN: 978-1-61779-163-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics